Initial public offerings scheduled to debut next week

NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Week of December 1:

Histogenics Corp. – Waltham, Mass., 4.3 million shares, priced $13 to $15, managed by Cowen, Needham, and Canaccord Genuity. Proposed Nasdaq symbol HSGX. Business: Developing a tissue implant to repair knee cartilage using regenerative medicine.